4D Pharma PLC
DelistedCIK 1830162fmd_0Y91R0685C9PANG7M49WPTFX7BManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2018 to Dec 31, 2021, 6 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
| Total revenues | – | 0 | 1 | 1 |
| Research and development | 28 | 29 | 23 | 22 |
| Selling, general and administrative | 11 | 10 | 13 | 16 |
| Total operating expenses | 39 | 41 | 36 | 38 |
| Operating income | (39) | (40) | (35) | (37) |
| Interest expense | 0 | 0 | 0 | 1 |
| Other non-operating income (expense) | 6 | 10 | 5 | 5 |
| Income before taxes | (33) | (30) | (31) | (32) |
| Income tax expense | – | – | (0) | (0) |
| Net income from continuing operations | – | – | (30) | (32) |
| Net income | (33) | (30) | (30) | (32) |